Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Oncology Reports
Published in: Current Oncology Reports 7/2020

01-07-2020 | Coronavirus | Invited Commentary

Transitioning to a New Normal in the Post-COVID Era

Authors: Di M. Jiang, Alejandro Berlin, Lesley Moody, Rajat Kumar, Breffni Hannon, Monika K. Krzyzanowska, Neesha Dhani, Heather Cole, Mary Elliott, Srikala S. Sridhar

Published in: Current Oncology Reports | Issue 7/2020

Login to get access

Excerpt

The COVID-19 pandemic has placed significant strains on health care systems worldwide, especially on routine cancer care. Cancer patients, owing to their disease and treatment, are at increased risk for contracting COVID-19 and developing severe outcomes [1]. They are also at risk for cancer progression if left untreated, making their care increasingly complex during the pandemic [2]. …
Literature
1.
2.
3.
Stukel TA, Schull MJ, Guttmann A, Alter DA, Li P, Vermeulen MJ, et al. Health impact of hospital restrictions on seriously ill hospitalized patients: lessons from the Toronto SARS outbreak. Med Care. 2008;46:991–7.CrossRef
4.
5.
Lala M, Li TR, de Alwis DP, Sinha V, Mayawala K, Yamamoto N, et al. A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation. Eur J Cancer. 2020;131:68–75.CrossRef
6.
Bauman JR, Temel JS. The integration of early palliative care with oncology care: the time has come for a new tradition. J Natl Compr Cancer Netw. 2014;12:1763–71.CrossRef
7.
Waterhouse D, et al. Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology survey. JCO Oncol Pract. 2020. https://​doi.​org/​10.​1200/​OP.​20.​00275 OP.20.00275.
8.
9.
Greenberg N, Docherty M, Gnanapragasam S, Wessely S. Managing mental health challenges faced by healthcare workers during COVID-19 pandemic. BMJ. 2020;368:m1211.CrossRef
10.
Nadler MB, Barry A, Murphy T, Prince R, Elliott MS. trategies to support health care providers during the COVID-19 pandemic. CMAJ. 2020;192:E522.CrossRef
Metadata
Title
Transitioning to a New Normal in the Post-COVID Era
Authors
Di M. Jiang
Alejandro Berlin
Lesley Moody
Rajat Kumar
Breffni Hannon
Monika K. Krzyzanowska
Neesha Dhani
Heather Cole
Mary Elliott
Srikala S. Sridhar
Publication date
01-07-2020
Publisher
Springer US
Published in
Current Oncology Reports / Issue 7/2020
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-020-00956-1

Other articles of this Issue 7/2020

Current Oncology Reports 7/2020 Go to the issue

Cardio-oncology (EH Yang, Section Editor)

New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity

Cardio-oncology (EH Yang, Section Editor)

Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues

Cardio-oncology (EH Yang, Section Editor)

Proteasome Inhibitor-Related Cardiotoxicity: Mechanisms, Diagnosis, and Management

Gynecologic Cancers (NS Reed, Section Editor)

Morcellation of the Uterus: Is There Any Place?

Melanoma (RJ Sullivan, Section Editor)

Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers

Cardio-oncology (EH Yang, Section Editor)

Prehabilitative Exercise for the Enhancement of Physical, Psychosocial, and Biological Outcomes Among Patients Diagnosed with Cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits